Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 6, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that in the interest of the health and safety of its shareholders, directors, officers,...
Jan 6, 2022Highlights Company's Impact on Advancing Cybersecurity Maturity in Health CareBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its second annual cybersecurity report to update stakeholders on the state of health...
-
Jan 5, 2022
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its first quarter of fiscal year 2022 on Thursday, Feb. 3, 2022. A news release will be...
-
Dec 22, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will virtually present at the 40th Annual J.P. Morgan Healthcare Conference via...
Dec 22, 2021Tests now available online through Everly Health and in-store at Winn-Dixie, Harveys Supermarket, and Fresco y MásBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical company, today announced the BD Veritor™ At-Home COVID-19 Test is now available for purchase through Everly Health, a...
-
Dec 21, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Embecta Corp. ("embecta"), the independent, publicly-traded company that will hold...
Dec 21, 2021Advances company's innovation focus on enabling new care settings and accelerating smart connected careBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in...
Dec 17, 2021BD COR™ MX for Infectious Disease Testing Receives CE Mark and is Final Instrument Introduced on BD COR™ SystemBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to include a new MX instrument for high-throughput...
Dec 15, 2021€70 Million Investment to Establish New Research Laboratories, Jobs in Software Engineering, Informatics and CybersecurityLIMERICK, IRELAND (15TH Dec. 2021) –BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to create more than 130 new jobs and invest €
Dec 9, 2021Stamford, Conn. – Dec. 9, 2021 – The global medical technology company, BD (Becton, Dickinson and Company), has committed $500,000 to improve quality of care and reduce health inequities for...
Dec 9, 2021- Acquisition complements BD's core portfolio - adding an innovative, broadly applicable surgical sealant to a suite of BD biosurgery products already relied upon in the operating room.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England...
Dec 8, 2021Addition of 100 local jobs will play key role in bolstering manufacturing capacity to supply the market with pre-filled flush syringes for use in health care settingsDROGHEDA, IRELAND (December 8, 2021) – BD (Becton Dickinson and Company), a leading global medical technology company, held a ribbon cutting ceremony today to announce the creation of 100 new...
Dec 6, 2021BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that "embecta" [pronounced em-BECK-tah] will be the name of the independent,...
Dec 2, 2021- Acquisition marks BD's entry point to the treatment of Chronic Venous Insufficiency -- adding transformative solutions to its existing venous disease portfolio with the potential to reshape patient care.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic...
Dec 1, 2021Progress Builds Strong Foundation for Bold 2030+ ESG Goals to Advance the World of Health for AllBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its 2021 Global Inclusion, Diversity and Equity (ID&E) Report. The...
-
Nov 30, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding testing for the COVID-19 Omicron variant of concern....
Nov 29, 2021Digital Health Pioneer to Focus on External Innovation; Becomes Co-Chair of BD Scientific Advisory BoardBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific...
Nov 24, 2021BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Francesca DeMartino has been named senior vice president of investor relations for the...
-
Nov 16, 2021New facility will expand BD’s capacity to supply the European market with pre-fillable syringes for use in applications such as vaccines and other biologic drugs; add 150 local jobs by 2024.
FRANKLIN LAKES, N.J. (November 16, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, broke ground on a €165 million ($200 million USD)...
Nov 12, 2021- Innovation agenda focuses on advancing human health through smart connected care, new care settings and chronic disease outcomesBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth and depth...
Nov 4, 2021- Fourth fiscal quarter revenues of $5.1 billion grew 7.3% on a reported basis or 5.9% on a currency-neutral basis.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021....
-
Nov 4, 2021
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter. The dividend...
Oct 28, 2021BARDA to Invest $24.7 Million for BD to Develop New Tests for Core Labs, Hospitals and Point-of-Care LocationsBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the formation of a strategic, public-private partnership with the Biomedical Advanced...
Oct 26, 2021Event will provide strategic update, with focus on company's innovation and growth agendasBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a virtual investor day on Friday, Nov. 12, 2021 at 8 a.m., which will...
Oct 26, 2021- BD Veritor™ At-Home COVID-19 Test is now available for purchase on Amazon.comBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has started to ship the first over-the-counter (OTC) COVID-19 rapid antigen test to...
Oct 22, 2021BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company's board of directors,...
Oct 18, 2021Building on More Than Two Decades of Achievements, BD Making Bold ESG Commitments to Advance the World of Health for AllBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new strategy to advance environmental, social and governance (ESG) initiatives, as...
-
Oct 13, 2021
New product is intended to support biologic drugs with high viscosity formulations*, complex design space requirements and support the delivery of medications for chronic diseases FRANKLIN LAKES,...
-
Oct 7, 2021New Manufacturing Lines Will Provide U.S. Government with Priority Access to Hundreds of Millions of Needles and Syringes; Bolster Supply Readiness
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government's access to safety injection devices through...
Oct 6, 2021Rotarex™ Rotational Excisional Atherectomy System is the first and only atherectomy and thrombectomy device indicated to treat in-stent restenosis in the United StatesBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance for expanded indications from the U.S. Food and Drug...
-
Oct 4, 2021
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its fiscal 2021 fourth quarter and full year financial results on Thursday, Nov. 4, 2021. BD will issue a press...
-
Sep 22, 2021BD FACSymphony™ A5 SE (Spectral Enabled) Cell Analyzer offers users flexibility of using spectral or conventional flow cytometry analysis
FRANKLIN LAKES, N.J., Sept. 22, 2021 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a spectral-enabled cell...
Sep 22, 2021Company Signs Business Ambition for 1.5°C, Committing to Scope 1, 2 and 3 Greenhouse Gas Reduction Targets in Line with 1.5°C Emissions Scenarios in Order to Reach Science-Based Net Zero Emissions by 2050BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, with support from a number of partners including Global Citizen, is proud to announce the company has...
Sep 21, 2021BD Offers Digitally Read SARS-CoV-2 Rapid Antigen Test and Optional Turn-key Solution in 'Learn to Return' ProgramBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been selected by the state of Washington as a digitally read, rapid antigen test...
Sep 2, 2021Canaan Facility Produced First-Ever Disposable Syringe; Continues to Enable COVID-19 Vaccination CampaignsCANAAN, Conn. (Sept. 2, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today celebrated the 60th anniversary of its manufacturing facility...
-
Aug 26, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will present at the following upcoming virtual investor conferences:...
Aug 25, 2021- BD Veritor™ At-Home COVID-19 Test is Over-the-Counter, Rapid Antigen Test Using Scanwell Health Mobile App to Deliver Reliable Results in 15 MinutesBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...
Aug 25, 2021BD COR™ PX/GX System integrates robotics and sample management software algorithms to automate the complete molecular laboratory workflow from sample processing to diagnostic test resultBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has launched a new, fully automated high-throughput diagnostic system using...
-
Aug 19, 2021
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announced tender offers to purchase for cash (i) any...
-
Aug 19, 2021
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the early tender results for its previously announced tender offers to purchase for cash (i) any and all of the...
Aug 11, 2021BD FACSymphony™ A1 Cell Analyzer offers powerful flow cytometry capabilities in a compact designBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry...
Aug 11, 2021BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Christopher DelOrefice has been named executive vice president and chief financial...
-
Aug 10, 2021
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced that it has amended its previously announced tender offers to purchase for cash each of its 3.875% Senior Notes...
Aug 10, 2021FRANKLIN LAKES, N.J. (Aug. 10, 2021) — BD (Becton, Dickinson and Company), a leading global medical technology company, along with Direct Relief and the National Association of Community Health...
Aug 6, 2021VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX™ System Identifies and Differentiates Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) variantsZARAGOZA, SPAIN and FRANKLIN LAKES, N.J. (Aug. 6, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec, today announced the CE...
-
Aug 5, 2021
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the...
Aug 5, 2021Reidy Will Join Board of Directors of Planned Diabetes Care SpinoffBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Christopher Reidy, 64, executive vice president, chief financial officer (CFO) and...
-
Aug 5, 2021
Third fiscal quarter revenues of $4.9 billion grew 26.9% on a reported basis. On a currency-neutral basis, revenues increased 22.0%. BD's COVID-19 testing revenues were $300 million, including BD...
-
Jul 29, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that management will be presenting at the UBS Genomics 2.0 and MedTech Innovations...
-
Jul 29, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the company will begin remediation for the February 4, 2020 BD Alaris™ System1 recall...